RBRobert J. Belland

Robert J. Belland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert J. Belland has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Deborah D. Crane

    Laboratories of *Human Bacterial Pathogenesis and ¶Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, MT 59840; §Department of Microbiology, University of Texas Health Science Center, San Antonio, TX 78229; and ∥Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110

    2 shared publications
  • Harlan D. Caldwell

    Laboratories of *Human Bacterial Pathogenesis and ¶Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, MT 59840; §Department of Microbiology, University of Texas Health Science Center, San Antonio, TX 78229; and ∥Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110

    2 shared publications
  • Daniel Hogan

    Laboratories of *Human Bacterial Pathogenesis and ¶Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, MT 59840; §Department of Microbiology, University of Texas Health Science Center, San Antonio, TX 78229; and ∥Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110

    1 shared publication
  • Daniel M. Hogan

    Laboratory of Human Bacterial Pathogenesis and §Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840; ‡Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; and ¶Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada R3E 0W3

    1 shared publication
  • Daniel Sturdevant

    Laboratories of *Human Bacterial Pathogenesis and ¶Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institutes of Health, Hamilton, MT 59840; §Department of Microbiology, University of Texas Health Science Center, San Antonio, TX 78229; and ∥Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110

    1 shared publication
  • Grant McClarty

    Laboratory of Human Bacterial Pathogenesis and §Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840; ‡Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; and ¶Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada R3E 0W3

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis

    by Robert J. Belland, Guangming Zhong, Deborah D. Crane, Daniel Hogan, Daniel Sturdevant, Jyotika Sharma, Wandy L. Beatty, Harlan D. Caldwell

    Chlamydia trachomatis is one of the most common bacterial pathogens and is the etiological agent of debilitating sexually transmitted and ocular diseases in humans. The organism is an obligate intracellular prokaryote characterized by a highly specialized biphasic developmental cycle. We have performed genomic transcriptional analysis of the chlamydial developmental cycle. This approach has led to the identification of a small subset of genes that control the primary (immediate-early genes) and secondary (late genes) differentiation stages of the cycle. Immediate-early gene products initiate bacterial metabolism and potentially modify the bacterial phagosome to escape fusion with lysosomes. One immediate early gene (CT147) is a homolog of the human early endosomal antigen-1 that is localized to the chlamydial phagosome; suggesting a functional role for CT147 in establishing the parasitophorous vacuole in a nonfusogenic pathway. Late gene products terminate bacterial cell division and constitute structural components and remodeling activities involved in the formation of the highly disulfide cross-linked outer-membrane complex that functions in attachment and invasion of new host cells. Many of the genes expressed during the immediate-early and late differentiation stages are Chlamydia -specific and have evolutionary origins in eukaryotic lineages.


  • Open Access

    Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes

    by Robert J. Belland, Marci A. Scidmore, Deborah D. Crane, Daniel M. Hogan, William Whitmire, Grant McClarty, Harlan D. Caldwell

    Chlamydia trachomatis is an obligate intracellular human bacterial pathogen that infects epithelial cells of the eye and genital tract. Infection can result in trachoma, the leading cause of preventable blindness worldwide, and sexually transmitted diseases. A common feature of infection is a chronic damaging inflammatory response for which the molecular pathogenesis is not understood. It has been proposed that chlamydiae have a cytotoxic activity that contributes to this pathology, but a toxin has not been identified. The C. trachomatis genome contains genes that encode proteins with significant homology to large clostridial cytotoxins. Here we show that C. trachomatis makes a replication-independent cytotoxic activity that produces morphological and cytoskeletal changes in epithelial cells that are indistinguishable from those mediated by clostridial toxin B. A mouse chlamydial strain that encodes a full-length cytotoxin caused pronounced cytotoxicity, as did a human strain that has a shorter ORF with homology to only the enzymatically active site of clostridial toxin B. Cytotoxin gene transcripts were detected in chlamydiae-infected cells, and a protein with the expected molecular mass was present in lysates of infected epithelial cells. The protein was present transiently in infected cells during the period of cytotoxicity. Together, these data provide compelling evidence for a chlamydial cytotoxin for epithelial cells and imply that the cytotoxin is present in the elementary body and delivered to host cells very early during infection. We hypothesize that the cytotoxin is a virulence factor that contributes to the pathogenesis of C. trachomatis diseases.